Stay updated on Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The study documents page now shows Revision: v3.3.4 and removes Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T04:24:51.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A consolidated Locations section listing study sites by state (Illinois, Indiana, Iowa, New Jersey, Pennsylvania) has been added, and the per-state location blocks have been removed; the revision is updated to v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T20:56:49.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The Publications note now clarifies PubMed auto-fill for publications and adds a Revision: v3.3.2 indicator; the previous PubMed wording and the Revision: v3.2.0 reference were removed.
    Difference
    0.1%
    Check dated 2025-11-25T11:23:27.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Deleted the government funding operating status notice from the page; core study content, eligibility criteria, and location information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:01:20.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No significant changes; only minor formatting differences observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:10:09.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Adds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T06:00:09.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Imprime PGG in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Imprime PGG in NSCLC Clinical Trial page.